Laboratory Corp. (LH) Tops Q2 EPS by 3c; Reaffirms FY11 Outlook
Tweet
Share
E-mailGet Alerts LH Hot Sheet
Price: $320.71 -0.63%
Revenue Growth %: +5.6%
Financial Fact:
Restructuring and other special charges: 22.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.6%
Financial Fact:
Restructuring and other special charges: 22.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.39 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Amer Sports raises Q3 2026 outlook, updates long-term targets
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
